Aronoff, «Epidemiology of Clostridium difficile infection, J Pharm Pract, vol.26, pp.464-475, 2013. ,
, «Traitement des infections digestives à Clostridium difficile : anciennes et nouvelles approches, 2011.
DOI : 10.1016/j.antinf.2011.03.002
, «Comment traiter une infection digestive à Clostridium difficile en 2014 ?,» Réanimation, n° %123, pp.284-297, 2014.
DOI : 10.1007/s13546-014-0867-z
«Infection à Clostridium difficile : physiopathologie, diagnostic et traitement,» Réanimation, pp.1255-263, 2005. ,
, , 2008.
, «Actualités sur l'épidémiologie et le diagnostic des infections à Clostridium difficile (ICD),» chez Journée annuelle d'échange, 2017.
,
«The changing epidemiology of Clostridium difficile infections, Clinical Microbiology Reviews, vol.23, pp.529-549, 2010. ,
,
,
,
Monnet, «Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, vol.13, p.18492, 2008. ,
«Clostridium difficile : une épidémie au service de la santé publique, Revue Médicale Suisse, vol.2, p.2274, 2006. ,
, European Centre for DiseasePrevention and Control, «Healthcare-associated infections: Clostridium difficile infections,» ECDC. Annual Epidemiological Report for, 2016.
Barbut et ICD-Raisin Working Group, «Clinical and microbiological features of Clostridium difficile infections in France: The ICD-RAISIN 2009 national survey, Médecine et maladies infectieuses, vol.43, pp.67-74, 2013. ,
, «Prévalence des infections à Clostridium difficile chez les patients hositalisés avec une diarrhée : résultats d'une étude français prospecive multicentrique,» La Presse Médicale, vol.44, pp.75-83, 2014.
DOI : 10.1016/j.lpm.2014.09.021
, «Community-acquired Clostridium difficile infection: an increasing public health threat,» Infection and Drug Resistance, vol.7, pp.63-72, 2014.
,
, «Epidemiology of community-associated Clostridium difficile infection, vol.173, pp.1359-1367, 2009.
«The epidemiology of community-acquired Clostridium difficile infection: a population-based study, » American Journal of Gastroenterology, vol.107, issue.%11, pp.89-95, 2012. ,
, Canadian Family Physician, vol.63, pp.97-99, 2017.
, «Intestinal Flora in New-Born Infants with a Description of a New Pathogenic Anaerobe, Bacillus Difficile, vol.49, pp.1390-402, 1935.
«Clinical and laboratory observations in Clostridium difficile colitis, Am J Clin Nutr, vol.33, pp.12521-2526, 1980. ,
, «Identification of Toxin Anegative, Toxin B-positive Clostridium difficile by PCR, vol.36, pp.2178-2182, 1998.
«Prevalence and genetic characterization of Toxin A variant strains of Clostridium difficile among adults and children with diarrhea in France, J Clin Microbiol, pp.2079-2083, 2002. ,
, «Characterization of a Toxin A-negative, Toxin B-positive strain of Clostridium Difficile, vol.60, pp.4633-4639, 1992.
, «Current status of Clostridium difficile infection epidemiology, vol.55, 2012.
, «Epidemiology of Clostridium difficile associated infections, vol.17, pp.405-410, 2001.
«Nosocomial acquisition of Clostridium difficile infection, N ENgl J Med, vol.320, pp.204-214, 1989. ,
«Examination of potential mechanisms to explain the association between proton pump inhibitors and Clostridium difficile infection, Antimicrobial Agents and Chemotherapy, vol.53, pp.4133-4137, 2009. ,
, Camus-Bouedjoro, «Les infections à Clostridium difficile en EHPAD»
«European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection, Clinical Microbiology and Infection, vol.20, pp.1-26, 2014. ,
, «Treatment of Clostridium difficile associated disease: old therapies and new strategies,» Lancet Infect Dis, n° %15, pp.549-57
, «Recent Progress for the Effective Prevention,» Infectious Diseases: Research and Treatment, vol.11, pp.1-4, 2018.
, , 2017.
«Clostridium difficile toxins: Mediators of inflammation, J Innate Immun, vol.4, pp.149-158, 2012. ,
, «Conduite à tenir : diagnostic, investigation, surveillance, et principes de prévention et de maitrise des infections à Clostridium difficile, vol.26, p.5, 2006.
, «Asymptomatic carriage of Clostridium difficile in French hospitals: preliminary results of the PORTADIFF study, 2017.
«Defecation frequency and timing, and stool form in the general population: a prospective study, » Gut, vol.33, pp.818-824, 1992. ,
, «Diagnostic des infections à Clostridium difficile, pp.67-73, 2011.
,
Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection,» Clinical Microbiology and Infection, n° %122, pp.63-81, 2016. ,
«Impact of recurrent Clostridium difficile infection: hospitalization and patient quality of life, J Antimicrob Chemother, vol.72, pp.2647-2656, 2017. ,
,
«Impact of Clostridium difficile infection on patients' quality of life, a French hospital prospective study, » OFID, vol.4, issue.1, p.393, 2017. ,
,
«Hospital cost of Clostridium difficile infection including the contribution of recurrences in French acute-care hospitals, Journal of Hospital Infection, vol.91, pp.117-122, 2015. ,
, «Updates on Clostridium difficile in Europe,» Advances in Experimental Medicine and Biology 1050, vol.8, pp.1-12, 2018.
, «Treatment of Clostridium difficile Infections,» Infect Dis Clin N Am, 2015.
,
«Clinical Practice Guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA, Clinical Infectious Diseases, vol.66, pp.1-48, 2018. ,
,
, «Fidaxomicin versus Vancomycin for Clostridium difficile infection, vol.364, pp.422-453, 2011.
, , 2015.
«Process and outcome of fecal microbiota transplants in patients with recurrent Clostridium difficile infection, » Society of Gastroenterology Nurses and Associates, vol.40, pp.411-419, 2017. ,
Transplantation, «Exploring ways to improve CDI outcomes,» Médecine et maladies infectieuses, 2017. ,
, «Clostridium difficile infection,» Infect Dis Clin N Am, n° %131, pp.489-495, 2017.
, «Colite à Clostridium difficile : nouvelles recommandations de prise en charge,» n° %110, pp.913-922, 2014.
«Duodenal infusion of donor feces for recurrent Clostridium difficile, N Engl J Med, pp.407-415, 1368. ,
Eckmann et V. Fuhrmann, «Therapy for Clostridium difficile infection -any news beyond Metronidazole and Vancomycin ?, » Expert Review of Clinical Pharmacology, vol.110, issue.11, pp.1239-1250, 2017. ,
, Direction Générale de la Santé, «Avis du Comité technique des infections nosocomiales et des infections liées aux soins relatif à la maîtrise de la diffusion des infections à Clostridium difficile dans les établissements de santé français, 2006.
Widmer, «Guidance document for prevention of Clostridium difficile infection in acute healthcare settings, Clinical Microbiology and Infection, vol.24, pp.1051-1054, 2018. ,
, «Clostridium difficile Colitis : Review of the Therapeutic Approach, vol.121, pp.385-394, 2014.
Barac et I. Milosevic, «Oral teicoplanin versus oral vancomycin for the treatment of severe Clostridium difficile infection: a prospective observational study, European Journal of Clinical Microbiology & Infectious Diseases, 2018. ,
«Clostridium difficile infection in the elderly : an update on management, Clinical Interventions in Aging, vol.112, pp.1799-1809, 2017. ,
Rizwan Sohail, «Successful use of nitazoxanide in the treatment of reccurent Clostridium difficile infection, BMJ Case Reports, 2011. ,
,
Ochsner, «Spectrum of activity and mode of action of REP3123, a new antibiotic to treat Clostridium difficile, Journal of Antimicrobial Chemotherapy, vol.163, pp.954-963, 2009. ,
Inhibitory effect of REP3123 on toxin and spore formation in Clostridium difficile, and in vivo efficacy in a hamster gastrointestinal infection model, Journal of Antimicrobial Chemotherapy, issue.63, pp.964-971, 2009. ,
«Comparative in vitro activity of REP3123 against Clostridium difficile and other anaerobic intestinal bacteria, Journal of Antimicrobial Chemotherapy, vol.169, pp.972-976, 2009. ,
,
and metabolism of CRS3123, a methionyl-tRNA synthetase inhibitor developed for treatment of Clostridium difficile, in a Phase I study, Antimicrobial Agents and Chemotherapy, vol.61, p.18, 2017. ,
,
,
«Cadazolid for the treatment of Clostridium difficile infection: results of two double-blind, placebo-controlled, non-inferiority, randomised phase III trials, Lancet Infectious Diseases, 2019. ,
«Surotomycin versus vancomycin in adults with Clostridium difficile infection : primary clinical outcomes from the second pivotal, randomised, double-blind, phase III trial, The journal of antimicrobial chemotherapies, vol.72, pp.3462-3470, 0112. ,
Blais et P. Pertel, «Multicenter, randomized clinical trial to compare the safety and efficacy of LFF571 and vancomycin for Clostridium difficile infections, Antimicrobial Agents and Chemotherapy, vol.59, p.13, 2015. ,
«Existing and investigational therapies for the treatment of Clostridium difficile infection : a focus on narrow spectrum, microbiotasparing agents,» Médecine et maladies infectieuses, n° %148, pp.1-9, 2018. ,
«Duodenal infusion of donor feces for recurrent Clostridium difficile, N Engl J Med, vol.368, pp.407-422, 2013. ,
, «Transplantation de microbiote fécal dans le cadre des infections à Clostridium difficile récidivantes : recommandations pour la pratique courante,» Hepato-gastro et oncologie digestive, vol.22, p.14, 2015.
,
,
, «European consensus conference on faecal microbiota transplantation in clinical practice,» Gut, n° %10, pp.1-12, 2017.
«Capsules for fecal microbiota transplantation in recurrent Clostridium difficile infection, JAMA, vol.318, 1979. ,
«Quel avenir pour la Transplantation de Microbiote Fécal en thérapeutique ?,» chez 8ème journée de l'intergroupe SPILF/SFGG ,
, American Gastroenterological Association
,
, «Scaling Safe Access to Fecal Microbiota Transplantation: Past, Present, and Future, vol.20, p.114, 2018.
«New and emerging therapies for Clostridium difficile infection,» Current Opinion Infectious Disease, vol.29, pp.546-554, 2016. ,
«Results from a randomized placebo-controlled clinical trial of a RBX2660 -a microbiota-based drug for the prevention of reccurent Clostridium difficile infection, Clinical Infectious Disease, vol.29, p.3, 2018. ,
,
,
Pfizer announces positive top-line results from phase 2 study of investigational Clostridium difficile vaccine for the prevention of C. Difficile infection ,
,
, «Case report: Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG, vol.21, pp.224-226, 1995.
, «Probiotics for Clostridium difficile-associated diarrhea: focus on Lactobacillus rhamnosus GG and Saccharomyces boulardii, vol.41, pp.1212-1221, 2007.
, , 2017.
,
«A randomized placebo-controlled trial of S. boulardii in combination with standard antibiotics for Clostridium difficile disease, The Journal of the American Medical Association, vol.271, pp.1913-1918, 1994. ,
,
«The search for a better treatment for recurrent Clostridium difficile disease: use of highdose vancomycin combined with S. boulardii, Clinical Infectious Disease, vol.31, pp.1012-1017, 2000. ,
,
«Saccharomyces boulardii freine l'augmentation de l'acide cholique durant une antibiothérapue chez le volontaire sain : un nouveau mécanisme potentiel dans la protection des diarrhées à Clostridium difficile,» chez JFHOD, 2017. ,
«Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease, » American Journal of Gastroenterology, vol.101, pp.812-822, 2006. ,
«Prevention of Clostridium difficile infection with S. boulardii: a systematic review, Can J Gastroenterol, vol.23, pp.817-821, 2009. ,
, «Probiotics and prevention of Clostridium difficile infection, vol.45, pp.114-119, 2017.
Evans, «Timely use of probiotics in hospitalized adults prevents Clostridium difficile infection: a systematic review with meta-regression analysis, » Gastroenterology, vol.152, pp.1889-1900 ,
«Comparative efficacy of treatments for Clostridium difficile infection : a systematic review and network metaanalysis,» The Lancet, vol.16, p.7, 2018. ,
,
, , p.2017
, Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea,» Clinical Infectious Diseases, pp.1-36, 2017.